Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 21, 2023

SELL
$224.99 - $256.14 $239,164 - $272,276
-1,063 Reduced 38.97%
1,665 $399,000
Q1 2023

May 11, 2023

SELL
$239.75 - $277.0 $157,036 - $181,435
-655 Reduced 19.36%
2,728 $687,000
Q4 2022

Feb 15, 2023

SELL
$241.42 - $282.29 $20,037 - $23,430
-83 Reduced 2.39%
3,383 $898,000
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $309,319 - $1.89 Million
1,252 Added 56.55%
3,466 $895,000
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $99,111 - $125,257
-418 Reduced 15.88%
2,214 $562,000
Q1 2022

May 05, 2022

BUY
$257.27 - $315.76 $84,641 - $103,885
329 Added 14.29%
2,632 $772,000
Q4 2021

Feb 07, 2022

BUY
$292.08 - $329.01 $22,198 - $25,004
76 Added 3.41%
2,303 $758,000
Q3 2021

Nov 10, 2021

SELL
$272.21 - $332.43 $11,432 - $13,962
-42 Reduced 1.85%
2,227 $678,000
Q2 2021

Aug 10, 2021

SELL
$225.08 - $271.69 $292,829 - $353,468
-1,301 Reduced 36.44%
2,269 $609,000
Q1 2021

May 13, 2021

BUY
$212.38 - $245.9 $386,531 - $447,538
1,820 Added 104.0%
3,570 $803,000
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $17,637 - $20,373
-83 Reduced 4.53%
1,750 $388,000
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $3,366 - $4,091
-19 Reduced 1.03%
1,833 $395,000
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $56,499 - $77,628
-439 Reduced 19.16%
1,852 $327,000
Q1 2020

May 14, 2020

SELL
$121.39 - $169.05 $397,552 - $553,638
-3,275 Reduced 58.84%
2,291 $317,000
Q4 2019

Mar 04, 2020

BUY
$133.47 - $153.48 $292,299 - $336,121
2,190 Added 64.87%
5,566 $855,000
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $457,110 - $494,482
3,376 New
3,376 $488,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Principal Street Partners, LLC Portfolio

Follow Principal Street Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Street Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principal Street Partners, LLC with notifications on news.